- Home
- AXSM vs IPAR Comparison
AXSM vs IPAR Comparison
Compare AXSM & IPAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AXSM | IPAR |
|---|---|---|
| Founded | 2012 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 2.6B |
| IPO Year | 2015 | 1988 |
Fundamental Metrics
Financial Performance| Metric | AXSM | IPAR |
|---|---|---|
| Price | $148.16 | $84.23 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 20 | 5 |
| Target Price | ★ $176.00 | $128.20 |
| AVG Volume (30 Days) | ★ 519.5K | 309.5K |
| Earning Date | 11-03-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 3.80% |
| EPS Growth | N/A | ★ 9.68 |
| EPS | N/A | ★ 5.13 |
| Revenue | $561,263,000.00 | ★ $1,463,838,000.00 |
| Revenue This Year | $66.20 | $3.42 |
| Revenue Next Year | $57.56 | $1.53 |
| P/E Ratio | ★ N/A | $16.45 |
| Revenue Growth | ★ 65.83 | 3.12 |
| 52 Week Low | $75.56 | $77.21 |
| 52 Week High | $152.94 | $148.15 |
Technical Indicators
Market Signals| Indicator | AXSM | IPAR |
|---|---|---|
| Relative Strength Index (RSI) | 56.94 | 48.69 |
| Support Level | $144.00 | $81.05 |
| Resistance Level | $150.00 | $84.52 |
| Average True Range (ATR) | 4.15 | 1.96 |
| MACD | -0.73 | 0.80 |
| Stochastic Oscillator | 57.42 | 94.07 |
Price Performance
Historical ComparisonAbout AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About IPAR Inter Parfums Inc.
Interparfums Inc operates in the fragrance business and produces and distributes a wide array of prestige fragrance and fragrance-related products. It sells its product under the brand which includes Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lacoste, Lanvin, Moncler, Montblanc, Rochas and Van Cleef & Arpels. The company operates in two operating segments namely European based operations, SA, and United States based operations.. The group sells its products to department stores, perfumeries, specialty stores, and domestic and international wholesalers and distributors.